User:Etienne Robillard/Notebook/Drospirenone
From OpenWetWare
(Difference between revisions)
| Line 2: | Line 2: | ||
* optical isomerism (C2) : a HSL (homoserine) lactone derivative ? | * optical isomerism (C2) : a HSL (homoserine) lactone derivative ? | ||
* A high risks of hyperkalemia (K+) was found with long-term use of Yasmin. [http://sante.canoe.ca/drug_info_details.asp?brand_name_id=2052 2] | * A high risks of hyperkalemia (K+) was found with long-term use of Yasmin. [http://sante.canoe.ca/drug_info_details.asp?brand_name_id=2052 2] | ||
| - | * Ethics of birth control with chiral | + | * Ethics of birth control with chiral Schiff base alkyloids in orthogonal Fmoc-carbonyl nucleophilic catalysis? See [http://en.wikipedia.org/wiki/Grignard_reagent Grignard reagent] . |
| + | * Hence, is there a Yb(OTf)3 (distereoselective) route to remote activation of Fmoc-protected alkylamines via MW catalysis of C(2)-symmetric amines, ie Drospirenone ? See http://www.organic-chemistry.org/abstracts/literature/979.shtm | ||
| + | |||
| + | |||
== References == | == References == | ||
| Line 8: | Line 11: | ||
# http://en.wikipedia.org/wiki/Drospirenone | # http://en.wikipedia.org/wiki/Drospirenone | ||
# http://en.wikipedia.org/wiki/Spironolactone | # http://en.wikipedia.org/wiki/Spironolactone | ||
| + | |||
| + | == See also == | ||
| + | |||
| + | [[Pyrrolidines]] | ||
Revision as of 11:45, 4 February 2013
- CYP450 mediated [1] (A spironolactone derived alkyloid)
- optical isomerism (C2) : a HSL (homoserine) lactone derivative ?
- A high risks of hyperkalemia (K+) was found with long-term use of Yasmin. 2
- Ethics of birth control with chiral Schiff base alkyloids in orthogonal Fmoc-carbonyl nucleophilic catalysis? See Grignard reagent .
- Hence, is there a Yb(OTf)3 (distereoselective) route to remote activation of Fmoc-protected alkylamines via MW catalysis of C(2)-symmetric amines, ie Drospirenone ? See http://www.organic-chemistry.org/abstracts/literature/979.shtm
